Trichotillomania

A disorder that involves recurrent, irresistible urges to pull out body hair.
The urges involve pulling out hair from the scalp, eyebrows, or other areas of the body.
Symptoms include compulsive hair pulling and hair loss, such as bald patches on the scalp. Social and work functioning may be affected.
Treatment options include counseling and medications, such as antidepressants.

 

Cluster Number:
Wiki Number: PW220
Diagnosis: Trichotillomania
US Patients: 0.6% to 4%
World Patients:
Sex Ratio: B;G10; M;F3
Age Onset: childhood or 9-13 and then continues into adulthood if there are underlying psychiatric causes
Brain Area: basal ganglia develop a habit and the frontal lobes don’t stop them; extra gray matter (interpretation)
Symptoms: Compulsive hair-pulling from scalp, eyebrows, eyelashes, face, arms and legs – and rarely, elsewhere,may also eat the hair
Progression: Can result in low self-esteem and fear of socializing
Causes: hereditary, pulls triggered by anxiety, depression, obsessive-compulsive disorder
Medications: clomipramine may help; naltrexone and fluoxetine, also ; some medications increase hair-pulling
Therapies: CBT- habit-reversal training, biofeedback, hypnosis; electronic hand-tracking equipment may help, support groups

Youtube Video:

Overcoming Trichotillomania: The Power of Awareness

Amazon or Library Book: The Hair Pulling “Habit” and You

Click the book to link or order from Amazon.

Support Group: bfrb.org; 831-0457-1004

(Body Focused Repetitive Disorders)

4 CURRENT ARTICLES
FROM PUBMED

The world-wide medical research
reports chosen for each diagnosis 

Clicking each title opens the
PubMed article’s summary-abstract.

  • Monoamine Oxidase Inhibitors for Trichotillomania: A Case Series
    by Jon E Grant on January 26, 2023

    PURPOSE/BACKGROUND: Despite several decades of research, there are no US Food and Drug Administration-approved medications for trichotillomania or medications generally approved in other geographical jurisdictions. Monoamine oxidase inhibitors show efficacy in the treatment of depression and some possible promise for obsessive compulsive disorder.

  • Developmental control of noradrenergic system by SLITRK1 and its implications in the pathophysiology of neuropsychiatric disorders
    by Minoru Hatayama on January 23, 2023

    SLITRK1 is a neuronal transmembrane protein with neurite development-and synaptic formation-controlling abilities. Several rare variants of SLITRK1 have been identified and implicated in the pathogenesis of Tourette's syndrome, trichotillomania, and obsessive-compulsive disorder, which can be collectively referred to as obsessive-compulsive-spectrum disorders. Recent studies have reported a possible association between bipolar disorder and schizophrenia, including a revertant of modern...

  • Duodenal diastatic perforation due to double gastric and jejunal trichobezoar in a patient with Rapunzel syndrome
    by Luisa Paola Garzón Hernández on January 16, 2023

    Rapunzel syndrome is a rare clinical entity in which a trichobezoar is produced by the ingestion of hair at the gastric level, extending in the form of a tail towards the duodenum. It occurs in young patients with trichotillomania and trichophagia. We present the case of a 24-year-old woman with a history of anxiety without treatment, who for 10 years presented trichotillomania and trichophagia, producing a picture of intestinal obstruction that required surgical intervention, evidencing a giant...

  • Trichoscopy: An Update
    by L Fernández-Domper on December 27, 2022

    Trichoscopy is a simple, noninvasive office procedure that can be performed using a handheld or digital dermatoscope. This tool has gained popularity in recent years, because it provides useful diagnostic information for hair loss and scalp disorders by enabling the visualization and identification of distinctive signs and structures. We present an updated review of the trichoscopic features described for some of the most common hair loss disorders seen in clinical practice. Dermatologists...